AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CLOTRIMAZOLE+BETAMETHASONE DIPROPIONATE+NEOMYCIN SULPHATE
23 registrations across 2 African markets— 22 active
Markets with CLOTRIMAZOLE+BETAMETHASONE DIPROPIONATE+NEOMYCIN SULPHATE
Recent registrations
CLOTRIMAZOLE+BETAMETHASONE DIPROPIONATE+NEOMYCIN SULPHATE in Africa — Regulatory Overview
CLOTRIMAZOLE+BETAMETHASONE DIPROPIONATE+NEOMYCIN SULPHATE is registered across 2 African markets with 23 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 23 registrations, 22 (96%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.